Cancer immunotherapy is a therapeutic strategy that harnesses cancer patients own immune system to specifically target cancer cells. A new class of newly developed drugs in cancer immunotherapy (called immune checkpoint inhibitors) can cause long lasting regression of tumors and prevent relapse but only a small number of patients currently benefit from these drugs.

This project seeks to increase our understanding of important aspects of gene regulation involving immunotherapy checkpoint inhibitors. This project will increase our understanding of the interaction of cancer cells and the immune system with implications for the treatment of cancer.

Research Area 
Project type 
Project Grant
Year of funding 
2016